ISS Wins DKK 300 Million Annual Deal to Manage Swiss Pharmaceutical Facilities

Zurich, Monday, 26 January 2026.
Transitioning from subcontractor to primary partner, ISS secures a mandate worth nearly DKK 300 million annually to deliver integrated services for a major Swiss life sciences company.